News & Perspective

Aug 21, 2017

Aug 21, 2017
Chik skin rash

France reports local chikungunya cluster

In other developments, a few more cases were reported in the Americas and mosquito trials showed a risk of spread in major Kenyan cities.

Jul 21, 2017

Jul 21, 2017
Oral rehydration solution

Yemen's cholera epidemic called 'worst ever' by Oxfam

In just over 3 months, Yemen has reported more than 368,000 cases, the most in a single year.

Apr 25, 2017

Apr 25, 2017
Anopheles mosquito emerging from water

Returning travelers cause sizable malaria burden in US

New study estimates about 2,100 travelers return with the disease each year and almost 1,500 need hospitalization.

Jul 07, 2016

Jul 07, 2016
Yellow fever vaccine

WHO cites 2-month window for battling yellow fever

Outbreak responders hope to get a jump on mosquitoes by scaling up vaccination during a dry period.

Mar 04, 2016

Mar 04, 2016
Rabbits

MERS antibody shows promise in rabbits; signs of infection noted in Kenyans

A human monoclonal antibody decreased viral load in rabbits, and MERS antibodies were found in Kenyans who tended animals.

Oct 19, 2015

Oct 19, 2015
Camel

Saudi Arabia reports 5 MERS cases, notes janitor cluster

Also, a new study found that 47% of Kenyan camels tested had evidence of MERS-CoV antibodies.

Sep 25, 2015

Sep 25, 2015
Ebola virus

Study: Chip test directly identifies Ebola virus

A UC–Santa Cruz team has developed a chip-based method to directly detect Ebola.

Sep 22, 2015

Sep 22, 2015
Antibiotic drug pile

Report notes alarming global levels of antibiotic resistance

The CDDEP report and maps provide an unprecedented look at the problem and include a range of data, some public for the first time.

Apr 01, 2015

Apr 01, 2015
Syringe and vials

Phase 1 trials of Ebola vaccine show good immune responses

The first two phase 1 trials of VSV-EBOV vaccine show good immune responses.

Feb 27, 2015

Feb 27, 2015
Ebola treatment in Guinea

Trial of Ebola drug ZMapp launches in Liberia, US

Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»